Ramsay David A
CIK 0001283292 Name as filed on the most recent filing
Filed as Ramsay David A (47)
182 transaction lines · from 47 filings · filed 2004-08-18 to 2025-12-19 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
- ISSUER Savara Inc 32 filings
- ISSUER LA Jolla Pharmaceutical Co 5 filings
- ISSUER Halozyme Therapeutics Inc 10 filings
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
182 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2025-12-19 |
Savara Inc SVRA |
S, Open-market sale | 20,000 disposed | 6.06 | 121,220.00 | Form 4, filing 0001193125-25-327035 | |
| 2025-03-31 |
Savara Inc SVRA |
P, Open-market purchase | 150,000 acquired | 2.78 | 416,250.00 | Form 4, filing 0000950170-25-048032 | |
| 2024-11-18 |
Savara Inc SVRA |
P, Open-market purchase | 100,000 acquired | 2.88 | 287,600.00 | Form 4, filing 0000950170-24-127869 | |
| 2023-05-26 |
Savara Inc SVRA |
P, Open-market purchase | 37,124 acquired | 2.63 | 97,599.00 | Form 4, filing 0001209191-23-032391 | |
| 2023-05-25 |
Savara Inc SVRA |
P, Open-market purchase | 12,876 acquired | 2.57 | 33,129.95 | Form 4, filing 0001209191-23-032391 | |
| 2023-05-24 |
Savara Inc SVRA |
P, Open-market purchase | 50,000 acquired | 2.56 | 127,800.00 | Form 4, filing 0001209191-23-032391 | |
| 2022-12-30 |
Savara Inc SVRA |
P, Open-market purchase | 29,000 acquired | 1.55 | 44,834.00 | Form 4, filing 0001209191-23-000057 | |
| 2022-12-29 |
Savara Inc SVRA |
P, Open-market purchase | 7,000 acquired | 1.54 | 10,752.00 | Form 4, filing 0001209191-23-000057 | |
| 2022-12-28 |
Savara Inc SVRA |
P, Open-market purchase | 3,293 acquired | 1.50 | 4,923.04 | Form 4, filing 0001209191-22-062838 | |
| 2022-12-23 |
Savara Inc SVRA |
P, Open-market purchase | 15,707 acquired | 1.44 | 22,665.20 | Form 4, filing 0001209191-22-062838 | |
| 2022-12-22 |
Savara Inc SVRA |
P, Open-market purchase | 41,414 acquired | 1.48 | 61,127.06 | Form 4, filing 0001209191-22-062420 | |
| 2022-12-20 |
Savara Inc SVRA |
P, Open-market purchase | 13,830 acquired | 1.50 | 20,758.83 | Form 4, filing 0001209191-22-062125 | |
| 2022-12-20 |
Savara Inc SVRA |
P, Open-market purchase | 3,586 acquired | 1.48 | 5,307.28 | Form 4, filing 0001209191-22-062420 | |
| 2022-12-19 |
Savara Inc SVRA |
P, Open-market purchase | 40,719 acquired | 1.49 | 60,834.19 | Form 4, filing 0001209191-22-062125 | |
| 2022-12-16 |
Savara Inc SVRA |
P, Open-market purchase | 341 acquired | 1.50 | 511.50 | Form 4, filing 0001209191-22-062125 | |
| 2022-11-23 |
Savara Inc SVRA |
P, Open-market purchase | 4,610 acquired | 1.44 | 6,633.79 | Form 4, filing 0001209191-22-058760 | |
| 2022-11-22 |
Savara Inc SVRA |
P, Open-market purchase | 15,495 acquired | 1.42 | 22,018.40 | Form 4, filing 0001209191-22-058760 | |
| 2022-11-21 |
Savara Inc SVRA |
P, Open-market purchase | 25,005 acquired | 1.42 | 35,532.10 | Form 4, filing 0001209191-22-058171 | |
| 2022-11-18 |
Savara Inc SVRA |
P, Open-market purchase | 16,100 acquired | 1.34 | 21,606.20 | Form 4, filing 0001209191-22-058171 | |
| 2022-11-17 |
Savara Inc SVRA |
P, Open-market purchase | 8,900 acquired | 1.27 | 11,303.00 | Form 4, filing 0001209191-22-058171 | |
| 2022-09-27 |
Savara Inc SVRA |
P, Open-market purchase | 73,893 acquired | 1.37 | 101,381.20 | Form 4, filing 0001209191-22-051327 | |
| 2022-09-26 |
Savara Inc SVRA |
P, Open-market purchase | 31,107 acquired | 1.38 | 43,052.09 | Form 4, filing 0001209191-22-051327 | |
| 2022-09-23 |
Savara Inc SVRA |
P, Open-market purchase | 30,000 acquired | 1.42 | 42,660.00 | Form 4, filing 0001209191-22-051327 | |
| 2022-09-20 |
Savara Inc SVRA |
P, Open-market purchase | 600 acquired | 1.45 | 870.00 | Form 4, filing 0001209191-22-050703 | |
| 2022-09-19 |
Savara Inc SVRA |
P, Open-market purchase | 1,400 acquired | 1.46 | 2,039.80 | Form 4, filing 0001209191-22-050703 | |
| 2022-09-16 |
Savara Inc SVRA |
P, Open-market purchase | 6,000 acquired | 1.44 | 8,652.00 | Form 4, filing 0001209191-22-050703 | |
| 2022-09-08 |
Savara Inc SVRA |
P, Open-market purchase | 29,000 acquired | 1.40 | 40,571.00 | Form 4, filing 0001209191-22-049138 | |
| 2022-09-07 |
Savara Inc SVRA |
P, Open-market purchase | 2,130 acquired | 1.38 | 2,950.05 | Form 4, filing 0001209191-22-049138 | |
| 2022-09-06 |
Savara Inc SVRA |
P, Open-market purchase | 870 acquired | 1.38 | 1,200.60 | Form 4, filing 0001209191-22-049138 | |
| 2022-09-01 |
Savara Inc SVRA |
P, Open-market purchase | 39,768 acquired | 1.42 | 56,470.56 | Form 4, filing 0001209191-22-048251 | |
| 2022-08-31 |
Savara Inc SVRA |
P, Open-market purchase | 39,494 acquired | 1.42 | 56,199.96 | Form 4, filing 0001209191-22-048251 | |
| 2022-08-30 |
Savara Inc SVRA |
P, Open-market purchase | 20,738 acquired | 1.41 | 29,261.32 | Form 4, filing 0001209191-22-048251 | |
| 2022-06-22 |
Savara Inc SVRA |
P, Open-market purchase | 39,000 acquired | 1.44 | 56,355.00 | Form 4, filing 0001209191-22-038640 | |
| 2022-06-21 |
Savara Inc SVRA |
P, Open-market purchase | 21,094 acquired | 1.38 | 29,109.72 | Form 4, filing 0001209191-22-038640 | |
| 2022-06-17 |
Savara Inc SVRA |
P, Open-market purchase | 39,906 acquired | 1.33 | 52,915.36 | Form 4, filing 0001209191-22-038640 | |
| 2021-12-30 |
Savara Inc SVRA |
P, Open-market purchase | 35,000 acquired | 1.30 | 45,360.00 | Form 4, filing 0001209191-21-071589 | |
| 2021-12-29 |
Savara Inc SVRA |
P, Open-market purchase | 15,000 acquired | 1.24 | 18,675.00 | Form 4, filing 0001209191-21-071589 | |
| 2021-12-17 |
Savara Inc SVRA |
P, Open-market purchase | 25,000 acquired | 1.13 | 28,225.00 | Form 4, filing 0001209191-21-070142 | |
| 2021-12-15 |
Savara Inc SVRA |
P, Open-market purchase | 15,000 acquired | 1.08 | 16,260.00 | Form 4, filing 0001209191-21-070142 | |
| 2021-12-10 |
Savara Inc SVRA |
P, Open-market purchase | 35,000 acquired | 1.04 | 36,365.00 | Form 4, filing 0001209191-21-069189 | |
| 2021-12-08 |
Savara Inc SVRA |
P, Open-market purchase | 13,157 acquired | 1.05 | 13,814.85 | Form 4, filing 0001209191-21-068660 | |
| 2021-12-07 |
Savara Inc SVRA |
P, Open-market purchase | 11,843 acquired | 1.05 | 12,399.62 | Form 4, filing 0001209191-21-068660 | |
| 2021-12-06 |
LA Jolla Pharmaceutical Co LJPC |
P, Open-market purchase | 3,000 acquired | 3.87 | 11,610.00 | Form 4, filing 0001209191-21-068221 | |
| 2021-12-06 |
LA Jolla Pharmaceutical Co LJPC |
P, Open-market purchase | 2,215 acquired | 3.82 | 8,461.30 | Form 4, filing 0001209191-21-068221 | |
| 2021-12-06 |
LA Jolla Pharmaceutical Co LJPC |
P, Open-market purchase | 1,000 acquired | 3.84 | 3,840.00 | Form 4, filing 0001209191-21-068221 | |
| 2021-12-06 |
LA Jolla Pharmaceutical Co LJPC |
P, Open-market purchase | 1,000 acquired | 3.81 | 3,810.00 | Form 4, filing 0001209191-21-068221 | |
| 2021-12-06 |
LA Jolla Pharmaceutical Co LJPC |
P, Open-market purchase | 1,000 acquired | 3.80 | 3,800.00 | Form 4, filing 0001209191-21-068221 | |
| 2021-12-06 |
LA Jolla Pharmaceutical Co LJPC |
P, Open-market purchase | 1,000 acquired | 3.75 | 3,750.00 | Form 4, filing 0001209191-21-068221 | |
| 2021-12-06 |
LA Jolla Pharmaceutical Co LJPC |
P, Open-market purchase | 785 acquired | 3.77 | 2,959.45 | Form 4, filing 0001209191-21-068221 | |
| 2021-12-03 |
LA Jolla Pharmaceutical Co LJPC |
P, Open-market purchase | 2,000 acquired | 3.63 | 7,260.00 | Form 4, filing 0001209191-21-068221 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- S, Open-market sale
- Open-market sale
- P, Open-market purchase
- Open-market purchase
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.
- Open-market purchase 143
- Open-market sale 39
- Option exercise 0
- Grant or award 0
- Tax withholding 0
- Disposition to the issuer 0
- In-the-money option exercise 0
How to cite this page
ebomi catalog. RAMSAY DAVID A, insider transactions. Retrieved 2026-08-20 from https://ebomi.com/insider/0001283292
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6